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ABSTRACT 
Background: Wastewater analysis is an innovative approach that allows monitoring illicit drug use at 
the community level. This study focused on investigating geographical differences in drug consumption 
by comparing epidemiological, crime and wastewater data. Methods: Wastewater samples were 
collected in 19 cities across Germany and Switzerland during one week, covering a population of 
approximately 8.1 million people. Self-report data and consumption offences for the investigated areas 
were used for comparison and to investigate differences between the indicators. Results: Good 
agreement between data sources was observed for cannabis and amphetamine-type stimulants, whereas 
substantial discrepancies were observed for cocaine. In Germany, an important distinction could be 
made between Berlin, Dortmund and Munich, where cocaine and particularly amphetamine were more 
prevalent, and Dresden, where methamphetamine consumption was clearly predominant. Cocaine 
consumption was relatively homogenous in the larger urban areas of Switzerland, although prevalence 
and offences data suggested a more heterogeneous picture. Conversely, marked regional differences in 
amphetamine and methamphetamine consumption could be highlighted. Conclusions: Combining the 
available data allowed for a better understanding of the geographical differences regarding prevalence, 
typology and amounts of substances consumed. For cannabis and amphetamine-type stimulants, the 
complementarity of survey, police and wastewater data could be highlighted, although notable 
differences could be identified when considering more stigmatised drugs (i.e., cocaine and heroin). 
Understanding illicit drug consumption at the national scale remains a difficult task, yet this research 
illustrates the added value of combining complementary data sources to obtain a more comprehensive 
and accurate picture of the situation.  
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1. INTRODUCTION 
The consumption of illicit drugs in a given population or community remains a partially hidden activity 
that cannot be directly measured nor totally unveiled. Traditionally, the nature, versatility and extent of 
this phenomenon are assessed through the use of indicators such as consumption surveys or descriptive 
statistics. The last decade has seen the emergence and refinement of wastewater-based epidemiology 
(WBE), which relies on quantitative measurement of specific biomarkers of illicit drug use in 
wastewater. Presented as a complementary approach to current surveillance methods (Amundsen and 
Reid, 2014; Been et al., 2015; Bramness et al., 2014; Reid et al., 2012, 2011), WBE has received much 
attention. Although further developments will most probably refine it in the near future, WBE already 
enables the gathering of unique spatio-temporal information about consumption (Ort et al., 2014). 
Nevertheless, information about consumers (e.g., age, sex, socio-economical status and history of drug 
use), crucial for policy makers, cannot be gathered by this approach, but requires the use of classical 
monitoring tools. Yet, these are also affected by some limitations such as the difficulty to obtain 
representative estimates, long study times, high costs and difficulties in reaching specific groups of 
regular users (Banta-Green and Field, 2011; Ort et al., 2014).  
In general, estimating and monitoring drug use relies on direct and indirect methods (European 
Monitoring Centre for Drugs and Drug Addiction, 2015a). The former are mainly based on general 
population surveys (GPS), where a representative sample of the population is questioned about illicit 
drug use. The latter rely on extrapolating information about drug use from other sources indirectly 
related to drug use such as police statistics, treatment data as well as WBE. Despite suffering from the 
abovementioned limitations, these methods provide a partial, yet informative perspective of the 
phenomenon. By bringing together different and complementary data sources, it is expected to obtain a 
more precise understanding of the dynamics of illicit drug use at the national level. 
In this study, samples collected from different wastewater treatment plants (WWTP) in Germany and 
Switzerland (including Liechtenstein) were analysed. Estimates of the average daily consumption of 
illicit drugs were computed based on these measurements and pharmacokinetics data available in the 
literature. Results obtained from wastewater analysis were compared to data derived from GPS and 
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consumption offences registered by police forces. The aim of this study was to evaluate geographical 
differences and formulate hypotheses explaining divergences in the data sets. The cities investigated in 
the context of this study are shown in Figure 1. Focus was set on the use of cocaine, cannabis, heroin, 
amphetamine, methamphetamine, and 3,4-methylene-dioxymethamphetamine (MDMA or ecstasy).  
2. MATERIALS AND METHODS 
2.1 Epidemiological data and police statistics 
General population survey data included the reported prevalence of use during the 12-months prior to 
questioning with a focus on the investigated areas (see Figure 1 and Table 1) (Kraus et al., 2015, 2014, 
2010a, 2010b, 2001; Social and Market Research Institute and Addiction Suisse, 2015). Reported 
substances were: cocaine, cannabis, amphetamine and amphetamine-type stimulants (ATS) – such as 
methamphetamine and MDMA (for Germany only) and heroin (for Switzerland only). For Germany, 
available data was representative of the Federal States (Bundesland) (Kraus et al., 2010a, 2010b, 2001), 
except for Berlin, where capture/recapture methods were used to derive the estimates (Kraus et al., 2015, 
2014). For Switzerland, survey data included responses provided by participants living within the 
catchments of the considered WWTP (Social and Market Research Institute and Addiction Suisse, 
2015). See Supplementary Material for more details about GPS data used. 
Police statistics consisted of the number of offences for illicit drug use registered in the investigated 
areas during 2013 (Switzerland) and 2014 (Germany). Data were expressed as number of offences per 
year per thousand inhabitants. Epidemiological data and police statistics were not available for 
Liechtenstein.  
2.2 Wastewater data 
Amphetamine, methamphetamine and MDMA were quantified in wastewater samples together with the 
specific urinary metabolites of cocaine (i.e., benzoylecgonine), cannabis (i.e., 9-carboxy-delta-9-
tetrahydrocannabinol, THC-COOH) and heroin (6-monoacetylmorphine, 6-MAM). 
Daily 24-hour composite raw wastewater samples were collected over 7 consecutive days in March 
2014, from 19 cities (in total 22 WWTPs) across Germany and Switzerland (including Liechtenstein), 
as shown in Figure 1 and Table 1. Wastewater samples were analysed using validated liquid-
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chromatographic tandem mass spectrometric methods. Details on the analytical procedures can be found 
in (Bijlsma et al., 2014) (samples from Germany), (Castiglioni et al., 2006) (Lugano), (Been et al., 2015) 
(Chur, Lausanne, Lucerne, Neuchatel and Sion) and (Berset et al., 2010) (Basel, Bern, Geneva, St. 
Gallen, Zurich, Winterthur and Liechtenstein (Bendern)). All laboratories are involved in the multi-city 
study published by the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction, 2015b) 
and the analytical performance of methods used were assured by the participation in external inter-
laboratory exercises.   
Average daily population normalised loads (concentrations multiplied by daily wastewater flows and 
divided by the number of inhabitants), back-calculations (daily consumption of parent compound based 
on estimated loads and excretion data) and the associated errors were estimated for each city using 
Monte Carlo simulations, following existing procedures (Been et al., 2015; Jones et al., 2014). The 
parameters used are reported in Tables 2 and 3. For Berlin, the results from the four WWTPs were 
merged to be representative of the catchment area covering the entire city.  
Nationwide estimates of illicit drug use were computed using a series of ordinary least squares and 
mixed effect models. The back-calculated amount of parent compound consumed in each city per day 
of the week was used as response variable. The number of inhabitants was used as predictor variable in 
ordinary regression analysis, while for mixed effect models, the day of the week was also included as 
(random) predictor variable. Additional information about wastewater data can be found in the 
Supplementary Material. 
3. RESULTS 
3.1 Population Surveys 
Estimates of last-year prevalence of cocaine, cannabis and ATS in the investigated cities are shown in 
Figures 2 – 3 and Table 4. 
The highest prevalence for cocaine (2.8%) was measured for Berlin, with much lower levels in the other 
Federal States (0.4-0.8%). In Switzerland, Lausanne was highest (2.3%), followed by Lucerne (1.2), 
Geneva (1.0%), Zurich (0.9%) and Winterthur (0.9%). For cannabis, the highest prevalence in Germany 
were reported for Berlin (11%) and Dortmund/Dülmen (7.3%), with lower figures for Dresden (4.0%) 
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and Munich (3.5%). In Switzerland, prevalence of cannabis use was far more homogeneous (average 
7.0 ± 2.2%), except for Sion and Lugano with very low levels (1.6% and 3.7%, respectively). Last-year 
prevalence data for amphetamine and ATS was available only for Germany, with the highest figures 
reported for Berlin and Dresden (see Figure S1). 
3.2 Police statistics  
Reported consumption offences per thousand inhabitants in German and Swiss cities are illustrated in 
Figures 2 – 5 and Table 4. Highest rates for cocaine in Germany were reported in Dortmund (0.42), 
followed by Munich (0.29) and Berlin (0.22). Particularly low offence rates were reported in Dresden 
and Dülmen. In Switzerland, highest rates were reported in Bern (5.9), Lausanne (3.6) and Biel (3.0). 
Heroin-related data was only available for Switzerland, where it depicted a situation similar to cocaine 
(see Figure S2). For cannabis, highest rates were reported in Munich and Dortmund (4.3 and 4.5, 
respectively), with the remaining cities ranging between 0.6 and 2. Slightly higher cannabis-related 
offences were reported in western Switzerland (between 8.4 and 13), compared to the eastern and 
southern parts (between 3.4 and 7.6). Data about MDMA-related offences was available only for 
Switzerland, where it showed a heterogeneous situation. Amphetamine offences were quite 
homogeneous in the northern cities of Germany (range 0.25 to 0.5), while the highest rate was reported 
in Munich (0.72). In Switzerland, there was a clear difference between south/west and north/east, with 
the former reporting lower rates (0-0.25) compared to the latter (0.2-0.65). For methamphetamine, the 
number of offences was generally low in the German cities (0 to 0.11), except for Dresden which 
reported offence rates of 0.95. In Switzerland, low rates were reported (0-0.06), except for Neuchatel, 
Biel and St. Gallen, where these were substantially higher (0.15-0.73).  
3.3 Wastewater data 
3.3.1 Drug loads 
Population normalised loads of target substances measured in WWTP in Germany, Switzerland and 
Liechtenstein are reported in Figures 2 – 5 and Table 4. Fluctuations in drug loads observed during the 
week are illustrated in Figures S3 and S4. Weekend samples for the WWTP of Berlin Münchenhofe 
were not available, thus, the results refer only to the WWTP of Berlin Ruhleben, Schönerlinde and 
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Wassmannsdorf. The contribution of drug loads measured during the week in Münchenhofe was, 
however, limited (i.e., only 3.3 % of the total), except for amphetamine which was in the same order of 
magnitude as the other WWTPs.  
Among German cities, highest benzoylecgonine loads were measured in Dortmund and Berlin (243.3 
and 200 mg.day-1.1000inhab-1). In Switzerland, highest per capita loads were measured in Zurich, 
followed by Basel and Geneva (598.2, 453.4 and 447.6  
mg.day-1.1000inhab-1, respectively). Lowest loads were measured in Bendern (LI) and Sion. 
For THC-COOH, a more homogeneous picture was obtained both in Germany and Switzerland. 
Nonetheless, Dortmund and Berlin still exhibited twice as high per-capita loads compared to the other 
German cities (74.5 and 58.9 versus approximately 30 mg.day-1.1000inhab-1). In Switzerland, loads 
ranged from 59 mg.day-1.1000inhab-1 in Lugano to 125 mg.day-1.1000inhab-1 in Neuchatel.  
In Germany, highest MDMA loads were measured in Berlin, followed by Munich, Dortmund and 
Dülmen (29.5, 18.0, 10.7 and 9.5 mg.day-1.1000inhab-1 respectively). In Switzerland, loads ranged from 
55.4 in Zurich to 3.7 mg.day-1.1000inhab-1 in Lugano.  
Consumption of amphetamine seemed to be mainly localised in the cities of Berlin, Dortmund and 
Dülmen (ranging from 67.6 to 138.3 mg.day-1.1000inhab-1). In Switzerland, amphetamine was 
predominant in the north-eastern part of the country (8.9 to 25.6 mg.day-1.1000inhab-1), while its 
occurrence was less marked in western and southern parts of the country (0 to 10.5 mg.day-1.1000inhab-
1). Bendern (Liechtenstein) showed results similar to western Switzerland (11.4 mg.day-1.1000inhab-1).  
Highest methamphetamine loads were measured in Dresden (133 mg.day-1.1000inhab-1). In Switzerland, 
consumption seemed to be mainly localized in the cities of Neuchatel, Zurich and Biel (33.4, 21.8 and 
19.1 mg.day-1.1000inhab-1, respectively).  
Occurrence of 6-MAM (exclusive metabolite of heroin) was monitored only in Switzerland, as shown 
in Figure S4. Highest loads were measured in the cities of Zurich, Winterthur and St. Gallen (17.7, 13.5 
and 12.1 mg.day-1.1000inhab-1, respectively), while other large cities (> 100’000 inhabitants) were 
characterized by similar loads (between 6.7 and 10.9 mg.day-1.1000inhab-1). In smaller catchments, 
substantially lower per capita loads were measured (between 1.9 and 2.7 mg.day-1.1000inhab-1), except 
for Biel which was in the same range as larger urban areas. No 6-MAM was detected in Bendern.  
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3.3.2 Consumption estimates 
Using measured loads and excretion data reported in Table 3, the amounts of pure substance (i.e., parent 
compound) initially consumed were back-calculated using Monte Carlo simulations. Results are 
reported in Table 5.  
Nationwide consumption estimates are given only for Switzerland as the size of the population sampled 
during the campaign corresponds to approximately 27% of the total Swiss population (sampled 
population: 2.2 million, total population in 2013: 8.14 (Swiss Federal Statistical Office, 2014)). 
Furthermore, estimates were limited to cocaine and MDMA as these are the only two substances 
detected in all cities. Scatterplots of consumption estimates as a function of the population are illustrated 
in Figure 6. Prior to regression analysis, data was log-transformed to correct for heteroscedasticity (i.e., 
unequal variances between observations).  
For cocaine, a mixed effect model was used to extrapolate both, the daily average and weekly 
consumption estimate for municipalities not included in the wastewater sampling campaign (see 
Supporting Material, Figure S5 and Table S1 for further details). As reported in Table 6, the nationwide 
average daily consumption of cocaine was estimated to approximately 8.8 kg of pure substance. In terms 
of weekly consumption, 61.6 kg of pure cocaine was estimated.  
For MDMA, mixed effect models did not provide satisfactory results, thus, an ordinary least squares 
model was used to extrapolate the nationwide daily average consumption which was estimated at 0.367 
kg.day-1 of pure MDMA (as reported in Table 6).  
4.  DISCUSSION 
4.1 Cocaine 
In Germany, the overlap observed between prevalence, offences and wastewater data suggests that 
cocaine consumption is predominant in the cities of Dortmund and Berlin, although lower prevalence 
was reported in Dortmund. This difference, however, may be due to methodological differences between 
survey estimates in Dortmund (and other German cities) and capture/recapture estimates as applied in 
Berlin. Firstly, capture/recapture methods are less likely to produce underestimates, and secondly, the 
survey estimates used apply to regions (Bundesland) rather than to cities. For the city of Munich, offence 
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data suggest a high occurrence of cocaine use, yet both prevalence and wastewater data indicate the 
contrary. In the case of Dresden, offence and wastewater data suggest limited cocaine consumption, 
whilst survey data indicate that prevalence is similar to Munich and Dortmund.  
In Switzerland, conventional indicators depicted a highly heterogeneous situation, in particular between 
larger urban areas (i.e., > 100’000 inhabitants), which showed substantial differences in prevalence and 
number of reported offences. Yet, these were less pronounced when observing results from wastewater 
analysis. Possible explanations for these discrepancies are reporting bias, concealment, stigmatization, 
city size, drug availability, as well as law enforcement activities, all of which strongly influence survey 
outcomes and offence rates. Still, an overlap between data sources was observed for urban areas with 
less than 100’000 inhabitants.  
According to prevalence data, there is a slightly higher cocaine consumption in Swiss compared to 
German cities, which is confirmed by wastewater analysis. This is in contradiction with nationwide 
figures, which suggest that last-year prevalence is higher in Germany compared to Switzerland (i.e., 0.8 
and 0.5%, respectively (Gmel et al., 2014; Pabst et al., 2013)). Yet, the small number of cities analysed 
in Germany limits the interpretation. Results from the analysis of benzoylecgonine were consistent with 
findings from the multi-city study reported by the EMCDDA (European Monitoring Centre for Drugs 
and Drug Addiction, 2015b; Ort et al., 2014). 
4.2 Cannabis 
Overall, prevalence and wastewater data showed a similar picture for cannabis consumption in 
Germany, while offence rates diverged slightly from the former indicators. Highest prevalence was 
reported for Berlin and Dortmund, with the latter having also the highest THC-COOH per capita loads. 
This could be due to its proximity to the Netherlands, where a more liberal drug policy on cannabis use 
is in force (Bijlsma et al., 2012; Thomas et al., 2012). Yet, no statistical difference in the measured loads 
could be found between Berlin and Dortmund (Wilcox Rank Sum p-value > α = 0.05). Similarly to 
cocaine, higher offence rates were reported in Munich, while both prevalence and wastewater data 
suggested that these were substantially lower than in Berlin and Dortmund.  
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Based on prevalence and wastewater data, cannabis consumption appear quite uniform across the 
investigated areas, except for the city of Sion where reported prevalence was particularly low compared 
to offence and wastewater results. In general, offence rates are more heterogeneous compared to the 
other two indicators. However, it should be noted that since October 1st 2013, use of cannabis by adults 
has been decriminalised and can now be punished with an administrative fine, without being recorded 
as a criminal offence (Conseil Fédéral, 2013). 
Comparisons between the two countries suggest that cannabis consumption is slightly higher in 
Switzerland, which is in agreement with national prevalence figures (i.e., 12-months prevalence of 4.5% 
and 5% in Germany and Switzerland, respectively (Gmel et al., 2014; Pabst et al., 2013)).  
Results from wastewater analysis obtained in this context were consistent with findings from the multi-
city study reported by the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction, 
2015b; Ort et al., 2014). 
4.3 Amphetamine-type stimulants  
The available indicators suggest that methamphetamine consumption in Germany was predominant in 
Dresden, while amphetamine consumption was substantially lower compared to the others cities. The 
occurrence of methamphetamine in Dresden is known to be related to its proximity to the Czech 
Republic, an important methamphetamine producer (European Monitoring Centre for Drugs and Drug 
Addiction, 2015c). Interestingly, available data suggests that consumption of methamphetamine is 
limited elsewhere, including Berlin and Munich, which are both in the eastern part of the country and 
thus, potentially affected by imports of methamphetamine from the Czech Republic. However, this is in 
agreement with the supposedly small-scale production (i.e., kitchen laboratories), whose outputs are 
thought to supply predominantly domestic and neighbouring markets (European Monitoring Centre for 
Drugs and Drug Addiction, 2014). Despite recent signs that its consumption is spreading (European 
Monitoring Centre for Drugs and Drug Addiction, 2015d), our data suggest that ATS consumption is 
still limited to border areas.  
The proximity of Dortmund to the Netherlands, which is known for its ATS production (European 
Monitoring Centre for Drugs and Drug Addiction, 2015d, 2014), does not seem to have an effect on the 
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availability and consumption of these substances. In fact, amphetamine loads were in the same range as 
those measured in Berlin and MDMA loads were below the values measured in Munich. Whilst 
comparisons with prevalence data should be interpreted carefully, as these do not distinguish between 
the type of ATS reported, our results confirm the more widespread use of amphetamine compared to 
methamphetamine (European Monitoring Centre for Drugs and Drug Addiction, 2015d, 2014). Similar 
findings were obtained in a recent study where wastewater samples from various cities in western 
Germany were analysed (Meyer et al., 2015). 
Catchment specific prevalence data on ATS was not available for Switzerland, yet offence rates and 
wastewater data for both MDMA and amphetamine showed similar patterns. The occurrence of MDMA 
seems to be predominant in larger urban areas, while smaller cities are generally less affected. For 
amphetamine, both data sources suggest higher prevalence rates in the north-eastern part of Switzerland. 
Offences related to methamphetamine use were highest in Neuchatel, Biel and St. Gallen. Wastewater 
analysis confirms these findings, except for St. Gallen where substantially lower loads were measured. 
Similarly to amphetamine use, methamphetamine consumption appears to be more widespread in the 
northern part of the country.  
In both countries, highest MDMA loads were measured in the largest cities, Berlin and Zurich, with the 
latter having the overall highest figures. Measurements in Munich were similar to those recorded in 
other larger urban areas (i.e., > 100’000 inhabitants) in Switzerland, while Dortmund and Dülmen 
showed loads similar to smaller cities in Switzerland. Amphetamine consumption was clearly more 
prevalent in the northern part of Germany. This is in agreement with national figures which suggest that 
its consumption is higher in Germany (12-months prevalence: 0.7% for ATS (Pabst et al., 2013)) 
compared to Switzerland (12-months prevalence: 0.4% for amphetamine and 0% for methamphetamine 
(Gmel et al., 2014)). In the case of methamphetamine, available data indicate that consumption is centred 
in some “hotspots”, while other areas included in this study are less affected.  
Results from wastewater analysis obtained in this context were in line with the multi-city study reported 
by the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction, 2015b; Ort et al., 2014). 
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4.4 Heroin 
The highest offence rates were reported in Lausanne, Bern and Biel, while the highest 6-MAM loads 
were measured in Zurich and Winterthur. Except for the latter two cities, the picture drawn from 
wastewater analysis suggests that heroin consumption is quite uniform throughout the country. In 
agreement with reported offences, Sion and Chur were the cities with the lowest per capita loads. There 
is evidence that the number of people being apprehended for consumption of highly stigmatized drugs 
is likely influenced by law enforcement strategies, in particular for heavy opiate users. Thus, classical 
surveillance systems provide a biased picture of the situation, rendering comparisons difficult.  
4.5 Consumption estimates 
Consumption estimates for each substance and city included in the sampling frame are reported in Table 
5. Whilst these figures are affected by various uncertainties, and should thus be interpreted carefully, 
they provide a rough idea of the amounts of substances consumed in the investigated areas. As 
previously discussed, amphetamine seems to be the predominant stimulant drug in Germany, while 
cocaine seems to be more widespread in Switzerland. Data for Liechtenstein suggest that cocaine is the 
main stimulant, with levels of use comparable to cities of similar size in Switzerland.  
Nationwide consumption estimates for cocaine and MDMA for Switzerland only derive from data 
collected in larger urban areas over the course of one week. These estimates may thus not correspond to 
consumption in smaller catchments not included in the study (i.e., less than 40’000 inhabitants), nor may 
they be representative of consumption throughout the year. Moreover, the excretion rates used for the 
calculations, which derive from pharmacological studies with a limited number of participants, and the 
potential degradation of biomarkers in sewers, might further affect the accuracy of the estimates. 
Nonetheless, these rough estimates allow assessing the order of magnitude of quantities consumed on a 
national scale and could potentially be used to estimate the associated money turnover.  
5. CONCLUSION 
Because illicit drug consumption is a complex phenomenon, the indicators considered in this study can 
only provide a partial perspective of the phenomenon and all suffer from limitations and uncertainties. 
Survey data may be biased by differential responses due to stigmatisation and hidden behaviours, which 
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are particularly pronounced for heroin and cocaine, whereas cannabis and other stimulants might be less 
affected. Offence data are obviously biased by law enforcement activities and strategies as well as the 
visibility of the drug scene and thus, may not be representative of the size of the drug using population. 
Munich is a clear example: offence rates related to all considered substances were among the highest 
while prevalence and wastewater data suggest low numbers of users and quantities. Moreover, this type 
of data does not always allow for distinguishing between users and dealers (who might confess personal 
use to avoid charges for trafficking). Finally, wastewater analyses allow estimating the amount and type 
of products consumed by the community, yet they are not capable of estimating the number and type of 
consumer.  
These limitations might explain the dissimilarities observed for cocaine-related data. As a result of its 
negative connotation and hidden consumption, it is likely more difficult to capture regular and 
marginalised users with current survey methods. Additionally, drug-related public nuisances influence 
the activities of law enforcement, making it difficult to draw conclusions from the number of reported 
offences. On the contrary, an interesting overlap could be highlighted for data related to cannabis, 
suggesting relatively homogeneous consumption across Germany and Switzerland. The findings support 
the hypothesis that cannabis consumption is less stigmatised and more widespread, and that current 
methods and wastewater analysis provide a realistic perspective of the situation. Similarly, a good 
overlap was observed for ATS-related data. A more widespread recreational use and thus, a limited 
number of regular/heavy users (difficult to measure) might explain the good agreement between the 
considered indicators. For Germany, prevalence data was not substance-specific (i.e., not possible to 
distinguish between amphetamine, methamphetamine and MDMA) and wastewater analysis provided a 
valuable tool to highlight geographical differences. Similarly, in Switzerland, where no recent survey 
was available, wastewater analysis allowed to identify geographical differences in amphetamine and 
methamphetamine use. Amphetamine was found to be more predominant in Germany and cocaine in 
Switzerland, confirming the north-south gradient of stimulants use in Europe (i.e., amphetamine being 
the main stimulant in northern countries, while cocaine is more widespread in the south of Europe 
(European Monitoring Centre for Drugs and Drug Addiction, 2015d, 2014)). Nonetheless, it would be 
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necessary to include additional areas, in particular for Germany, in order to obtain a more precise image 
of the situation at the national level.  
The findings support some of the existing hypotheses about regional features, but also provide additional 
evidence about geographical particularities. Understanding illicit drug consumption on a national scale 
remains a difficult task, however, the findings of this research illustrate how the combination of different 
and complementary data sources allows for obtaining a more accurate picture of the situation. The 
retrieved information can be used to monitor changes in drug use, both at the national and international 
scale, identify potential dangers, promote the setup of specific interventions (e.g., targeted surveys, 
prevention campaigns and/or police actions), understand the structure of drug markets and guide future 
drug policies. Although wastewater analysis does not provide direct information about users, its ability 
to provide close to real-time data and its potential integration in existing monitoring programs make it 
a valuable tool to help understanding illicit drug consumption.  
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Table 1: Summary of major characteristics of the sampled WWTP and period when the considered surveys were 
carried out. a) Reported population corresponds to figures provided by the WWTP personnel.  b) No samples 
collected on weekend. TP: Time-proportional, VP: Volume-proportional (*2h time-prop. 24h volume-prop.), FP: 
Flow-proportional, NA: Not available. Grey shading: no previous WBE data (first WBE data in this study) 
Country City/WWTP aPopulation 
Typical 
daily flow 
[m3.day-1] 
Sampling 
Approach 
Period Survey 
Germany 
Dortmund 371’788 90’000 NA 12.03-18.03.14 2000 
Dülmen 34’495 7’500 TP 12.03-18.03.14 2000 
Dresden 593’050 110’000 VP 11.03-17.03.14 2009 
Munich 1’000’000 330’000 TP 12.03-18.03.14 2009 
bBerlin 
Münchehofe 
290’000 42’000 VP* 
11.03-14.03.14, 
17.03.14 
2010-2012 
Berlin  
Ruhleben 
1’300’000 210’000 VP* 10.03-16.03.14 
Berlin 
Schönerlinde 
750’000 85’000 VP* 11.03-17.03.14 
Berlin 
Wassmannsdorf 
1’500’000 180’000 VP* 11.03-17.03.14 
Switzerland 
Basel 260’000 77’000 VP 18.03-24-03.14 2013-2014 
Bern 206’655 65’000 VP 18.03-24-03.14 2013-2014 
Biel 82’285 37’065.6 VP 18.03-24-03.14 2013-2014 
Chur 52’800 12’000 FP 18.03-24-03.14 2013-2014 
Geneva 417’200 140’000 VP 18.03-24-03.14 2013-2014 
Lausanne 220’000 108’000 FP 18.03-24-03.14 2013-2014 
Lugano 103’000 50’000 TP 18.03-24-03.14 2013-2014 
Lucerne 174’800 75’000 VP 18.03-24-03.14 2013-2014 
Neuchatel 50’000 17’000 VP 18.03-24-03.14 2013-2014 
Sion 45’000 20’380 TP 18.03-24-03.14 2013-2014 
St.Gallen 52’000 17’800 VP 18.03-24-03.14 2013-2014 
Winterthur 125’000 40’000 VP 18.03-24-03.14 2013-2014 
Zurich 410’000 170’000 VP 18.03-24-03.14 2013-2014 
Liechtenstein Bendern 37’000 25’000 TP 18.03-24-03.14 NA 
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Table 2: General parameters used in Monte Carlo simulations to estimate daily mass loads [g.day-1] of illicit drugs 
and their metabolites. µ = mean, SE = standard error. 
 µ SE Distribution Note 
Flow Daily flow [L.day-1] 20% of daily flow 
Normal  
(µ, SE2) 
Based on findings by Ort et al. (Ort 
et al., 2010a, 2010b), the error 
associated to daily flow 
measurements (S.E.) was estimated 
as 20% of the total daily flow. 
Substance 
concentration 
Measured concentration  
[ng.L-1] 
25% of measured 
concentration 
Normal  
(µ, SE2) 
From a preliminary evaluation of 
an inter-laboratory test, an average 
deviation of 25% from the 
expected values was reported by 
the participating laboratories. 
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Table 3: Compound specific parameters used in Monte Carlo simulations to back-calculate the amounts of parent 
compound initially consumed.  µ = mean, SE = standard error.  
 Substance µ SE Distribution Note 
Excretion 
rates 
Benzoylecgonine 30.58% 3.35% 
Beta (a,b) 
Inverse-variance weighted 
average. Data derived from 
summary in (Khan and 
Nicell, 2012, 2011) 
MDMA 15.78% 1.83% 
Amphetamine 29.12% 0.93% 
Methamphetamine 28.56% 2.59% 
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Table 4: Summary of prevalence, offences (per thousand inhabitants) and wastewater (in  
[mg.day-1.1000 inhabitants-1]) data for all cities investigated in the context of this study. a) Population normalised 
loads of benzoylecgonine, the major metabolite of cocaine; b) Population normalised loads of 6-
monoacetylmorphine, the exclusive metabolite of heroin.    
City 
Cocaine Cannabis MDMA 
Prevalence Offences aWastewater Survey Offences Wastewater Survey Offences Wastewater 
 Basel 0.04% 1.13 453.5 7.6% 4.52 - - 0.1 23.4 
Berne 0.2% 5.93 365.1 8.1% 12.68 - - 0.2 18.8 
 Biel 0.6% 3.01 239.6 8.1% 10.53 - - 0.2 9.7 
 Chur 0% 1.91 130.6 8.5% 5.46 78.4 - 0.1 8.6 
 Geneva 1.0% 1.42 447.6 7.8% 8.77 - - 0 21.3 
 Lausanne 2.3% 3.58 311.9 10.0% 12.95 116.8 - 0.2 20.4 
 Lugano 0.1% 1.81 242.0 3.7% 3.54 59.1 - 0.1 3.7 
Lucerne 1.2% 1.46 337.4 7.2% 3.37 93.4 - 0.1 13.0 
Neuchatel 0.3% 2.06 105.8 9.0% 4.86 125.4 - 0.3 5.0 
 Sion 0.1% 1.87 71.1 1.6% 8.44 86.4 - 0.2 8.3 
 St. Gallen 0.1% 1.64 351.1 6.1% 4.64 - - 0.2 29.9 
 Winterthur 0.9% 0.85 329.8 6.1% 6.51 - - 0.1 14.9 
Zurich 0.9% 1.79 598.3 8.1% 7.60 - - 0.3 55.4 
Bendern - - 140.0 - - - - - < LOQ 
Dortmund 0.8% 0.42 243.3 7.3% 4.53 74.5 - - 11.3 
Dülmen  - 0.03 31.8   0.64 34.5 - - 9.5 
Dresden 0.5% 0.02 8.4 4.0% 1.36 31.3 - - 4.8 
Munich 0.4% 0.29 79.5 3.5% 4.28 34.4 - - 18.1 
Berlin 2.8% 0.22 200.0 11.3% 2.00 58.9 - - 29.5 
 
Table 4 (continued) 
City 
Amphetamine Methamphetamine Heroin 
Offences Wastewater Offences Wastewater Offences bWastewater 
 Basel 0.21 16.6 0.02 14.1 0.63 7.4 
Berne 0.55 18.1 0.06 10.2 5.65 7.9 
 Biel 0.37 19.3 0.22 19.1 3.57 8.8 
 Chur 0.24 8.9 0 2.1 1.14 < LOQ 
 Geneva 0.03 < LOQ 0.01 < LOQ 1.73 9.6 
 Lausanne 0.14 7.3 0.02 3.8 3.57 7.2 
 Lugano 0.02 < LOQ 0 < LOQ 0.41 6.7 
Lucerne 0.30 25.2 0.01 10.2 0.82 7.1 
Neuchatel 0.16 10.5 0.73 33.4 0.67 < LOQ 
 Sion 0.25 < LOQ 0.04 0.5 0.62 1.9 
 St. Gallen 0.64 23.5 0.15 5.1 3.03 8.8 
 Winterthur 0.25 19.8 0.03 7.9 0.86 13.4 
Zurich 0.41 25.7 0.07 21.8 0.64 17.7 
Bendern - 11.4 - < LOQ   < LOQ 
Dortmund 0.50 138.3 0.02 10.2 - - 
Dülmen 0.26 67.6 0.00 8.9 - - 
Dresden 0.28 22.0 0.95 133.0 - - 
Munich 0.72 22.2 0.11 11.0 - - 
Berlin 0.25 115.8 0.04 8.1 - - 
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Table 5: 7-day back-calculated average illicit drug consumption [grams.day-1] (Standard Error). a) 7-day average 
calculated from three out four WWTP in Berlin (weekend included). b) 5-day average calculated from the four 
WWTP in Berlin (weekend excluded).  
 Population 
Cocaine 
(Benzolyecgonine) 
MDMA Amphetamine Methamphetamine 
Dortmund 371’788 313.2 (120.5) 26.8 (11.2) 176.9 (65.6) 13.4 (5) 
Dülmen 34’495 3.8 (1.6) 2.1 (0.9) 8 (3) 1.1 (0.4) 
Dresden 593’050 17.2 (6.6) 18.1 (7.9) 44.9 (17.1) 278.2 (104.1) 
Munich 1’000’000 274.9 (115.4) 115.8 (51.3) 76.4 (30.3) 38.8 (14.4) 
aBerlin 3’550’000 2456.9 (597.1) 672.4 (172.2) 1413.8 (305.7) 102.1 (102.1) 
bBerlin 3’840’000 2212.1 (572.6) 690.1 (690.1) 1374.6 (310.7) 100.7 (26.4) 
Basel 260’000 408.1 (155.8) 38.9 (17.3) 14.8 (5.8) 13 (4.8) 
Bern 206’655 261.2 (98.7) 25 (12.1) 12.9 (4.7) 7.5 (2.9) 
Biel 82’285 68.3 (26.2) 5.1 (2.3) 5.5 (2) 5.5 (2.3) 
Chur 52’800 23.9 (9.3) 2.9 (1.3) 1.6 (0.6) 0.4 (0.2) 
Geneva 417’200 646.4 (247.9) 56.9 (26.3) 6.8 (2.6) 4.5 (1.8) 
Lausanne 220’000 237.5 (91.9) 28.8 (13.7) 5.5 (2.1) 3 (1.2) 
Lugano 103’000 86.2 (32.8) 2.4 (1) 1.4 (0.5) 0.2 (0.1) 
Lucerne 174’800 204.1 (81.5) 14.6 (6.9) 15.1 (5.7) 6.3 (2.4) 
Neuchatel 50’000 18.3 (7.1) 1.6 (0.8) 1.8 (0.7) 5.9 (2.3) 
Sion 45’000 11.1 (4.2) 2.4 (1.2) 0 (0) 0.1 (0.1) 
St. Gallen 52’000 63.2 (24.4) 10 (4.4) 4.2 (1.8) 0.9 (0.4) 
Winterthur 125’000 142.7 (55.6) 11.9 (5.2) 8.5 (3.1) 3.5 (1.4) 
Zurich 410’000 849 (330.6) 145.7 (77.2) 36.2 (14.6) 31.5 (11.8) 
Bendern (Li) 74’000 17.9 (6.9) 1.7 (0.7) 1.5 (0.6) 0.6 (0.2) 
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Table 6: Nationwide estimates for cocaine and MDMA [kg.day-1]. Total weekly figures were calculated as the 
sum of the values measured and extrapolated for each day of the week. For MDMA this was not possible and an 
ordinary least squares regression was used, which does not allow extrapolating day-by-day consumption.      
  
Cocaine (BE) 
[kg.day-1] 
MDMA  
[kg.day-1] 
Considered 
Population 
Measured 
(Wastewater) 
7-day average 3.0 0.346 
2’198’740 
Weekly 21.2 2.4 
Extrapolated 
7-day average 5.8 0.023 5’793’612 
Weekly 40.4 - 
Total 
7-day average 8.8 0.367 
7’992’352 
Weekly 61.6 - 
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FIGURES 
 
Figure 1: Cities investigated in the context of the study.    
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Figure 2: 12-months prevalence for cocaine and cannabis in Berlin and the federal states of Northrhein-Westfalia 
(Dortmund and Dülmen), Saxony (Dresden) and Bavaria (Munich). Reported consumption offences per year per 
thousand inhabitants. Average population normalised loads  
[mg.day-1.1000inhab-1]. Only data from three of the four WWTP sampled in Berlin are reported (weekend data 
were missing for Berlin-Münchehofe). 
 25 
 
Figure 3: 12-months prevalence, reported consumption offences per year per thousand inhabitants and average 
population normalized loads [mg.day-1.1000 inhabitants-1], for cocaine and cannabis in Switzerland and 
Lichtenstein (wastewater data only). Wastewater samples from Geneva, Bern, Biel, Basel, Winterthur, Zurich and 
Bendern, were not analysed for THC-COOH. 
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Figure 4: Average population normalised loads [mg.day-1.1000 inhabitants-1] for MDMA, amphetamine and 
methamphetamine measured in Germany. Reported offences per year per thousand inhabitants in Germany. 
Offences data for MDMA was not available.   
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Figure 5: Reported consumption offences (per year per thousand inhabitants) and average population normalised 
loads [mg.day-1.1000 inhabitants-1] for MDMA, amphetamine and methamphetamine measured in Switzerland and 
Liechtenstein.  
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Figure 6: Scatter plot of estimated cocaine (based on benzoylecgonine loads) and MDMA consumption as a 
function of the size of the population. Line: ordi 
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